<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06974925050201</udiDi>
    <basicUdiDi>697492505000002T6</basicUdiDi>
    <tradeName>Inflammation Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>BYZKB0204</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T21:33:27.941Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050225</udiDi>
    <basicUdiDi>697492505000002T6</basicUdiDi>
    <tradeName>Inflammation Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>BYZKB0302</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T21:33:27.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050232</udiDi>
    <basicUdiDi>697492505000002T6</basicUdiDi>
    <tradeName>Inflammation Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>BYZKB0303</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T21:33:27.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050249</udiDi>
    <basicUdiDi>697492505000002T6</basicUdiDi>
    <tradeName>Inflammation Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>BYZKB0304</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T21:33:27.572Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050256</udiDi>
    <basicUdiDi>697492505000002T6</basicUdiDi>
    <tradeName>Inflammation Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>BYZKB0401</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T21:33:27.465Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050263</udiDi>
    <basicUdiDi>697492505000002T6</basicUdiDi>
    <tradeName>Inflammation Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>BYZKB0402</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T21:33:27.082Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925054933</udiDi>
    <basicUdiDi>697492505000025TJ</basicUdiDi>
    <tradeName>Hypertension Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W01021521</emdnCode>
    <emdnDescription>MULTICOMPONENT IMMUNOCHEMISTRY CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CFA0301</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:49:06.243Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925054124</udiDi>
    <basicUdiDi>697492505000022TC</basicUdiDi>
    <tradeName>Tumor Marker Speciality Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102152005</emdnCode>
    <emdnDescription>TUMOUR MARKER CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CEA0401</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:49:02.253Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925051475</udiDi>
    <basicUdiDi>697492505000008TJ</basicUdiDi>
    <tradeName>Specific Protein Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01021521</emdnCode>
    <emdnDescription>MULTICOMPONENT IMMUNOCHEMISTRY CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CAB0102</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:49:01.454Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925051536</udiDi>
    <basicUdiDi>697492505000008TJ</basicUdiDi>
    <tradeName>Specific Protein Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01021521</emdnCode>
    <emdnDescription>MULTICOMPONENT IMMUNOCHEMISTRY CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CAB0202</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:40:10.600Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925051598</udiDi>
    <basicUdiDi>697492505000008TJ</basicUdiDi>
    <tradeName>Specific Protein Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01021521</emdnCode>
    <emdnDescription>MULTICOMPONENT IMMUNOCHEMISTRY CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CAB0302</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:40:10.153Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925054193</udiDi>
    <basicUdiDi>697492505000022TC</basicUdiDi>
    <tradeName>Tumor Marker Speciality Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102152005</emdnCode>
    <emdnDescription>TUMOUR MARKER CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CEA0402</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:40:06.581Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925054261</udiDi>
    <basicUdiDi>697492505000022TC</basicUdiDi>
    <tradeName>Tumor Marker Speciality Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102152005</emdnCode>
    <emdnDescription>TUMOUR MARKER CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CEA0403</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:40:05.880Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925054971</udiDi>
    <basicUdiDi>697492505000025TJ</basicUdiDi>
    <tradeName>Hypertension Markers Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W01021521</emdnCode>
    <emdnDescription>MULTICOMPONENT IMMUNOCHEMISTRY CONTROLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CFA0302</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-13T03:39:56.506Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050720</udiDi>
    <basicUdiDi>B-06974925050720</basicUdiDi>
    <tradeName>Coagulation Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BYZKF0303</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T11:49:52.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050683</udiDi>
    <basicUdiDi>B-06974925050683</basicUdiDi>
    <tradeName>Coagulation Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BYZKF0203</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T11:49:51.587Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050645</udiDi>
    <basicUdiDi>B-06974925050645</basicUdiDi>
    <tradeName>Coagulation Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BYZKF0103</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T11:49:50.790Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050515</udiDi>
    <basicUdiDi>B-06974925050515</basicUdiDi>
    <tradeName>Clinical Chemistry Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0101050101</emdnCode>
    <emdnDescription>ASSAYED MULTICOMPONENT CONTROLS (CC)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BYZKD0303</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T11:49:47.204Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050430</udiDi>
    <basicUdiDi>B-06974925050430</basicUdiDi>
    <tradeName>Clinical Chemistry Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0101050101</emdnCode>
    <emdnDescription>ASSAYED MULTICOMPONENT CONTROLS (CC)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BYZKD0103</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T11:49:45.980Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974925050478</udiDi>
    <basicUdiDi>B-06974925050478</basicUdiDi>
    <tradeName>Clinical Chemistry Control</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Zhengzhou Bioyuan Biotech Co. Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000021426</manufacturerSrn>
    <authorisedRepresentativeName>QbD RepS BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000040</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0101050101</emdnCode>
    <emdnDescription>ASSAYED MULTICOMPONENT CONTROLS (CC)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BYZKD0203</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T11:49:45.194Z</lastUpdated>
  </row>
</eudamedExport>